Amanote Research
Register
Sign In
Role and Timing of New Drugs in CLL
Hematological Oncology
- United Kingdom
doi 10.1002/hon.2397
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2017
Authors
Michael Hallek
Publisher
Wiley
Related search
Review New Drugs in Multiple Myeloma – Role of Carfilzomib and Pomalidomide
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
Role of Drug Metabolism Studies in the Development of New Drugs.
Folia Pharmacologica Japonica
Pharmacology
Php76 - Analysis of Approval Timing for 89 New Drugs in Italy From January 2015 to May 2018
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Role of Chirality in Drugs
Organic & Medicinal Chemistry International Journal
New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Regulatory Science Plays an Important Role in the Global Development of New Drugs
Folia Pharmacologica Japonica
Pharmacology
The Role of Medical Structural Genomics in Discovering New Drugs for Infectious Diseases
PLoS Computational Biology
Molecular Neuroscience
Evolution
Ecology
Genetics
Behavior
Molecular Biology
Systematics
Simulation
Cellular
Computational Theory
Mathematics
Modeling
The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in the New Drugs Era.
Mediterranean Journal of Hematology and Infectious Diseases
Infectious Diseases
Hematology
CLL
Bone Marrow Transplantation
Transplantation
Hematology